{
  "ticker": "VRTX",
  "year": 2024,
  "quarter": 3,
  "last_updated": "2025-04-19T08:57:46.400210",
  "count": 46,
  "transactions": [
    {
      "id": 113666,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-08-30",
      "transaction_shares": "3784",
      "transaction_price": "499",
      "transaction_type": "S",
      "shares_after_transaction": "9994"
    },
    {
      "id": 113707,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-30",
      "transaction_shares": "646",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5081"
    },
    {
      "id": 140046,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-08-30",
      "transaction_shares": "3784",
      "transaction_price": "499",
      "transaction_type": "S",
      "shares_after_transaction": "9994"
    },
    {
      "id": 140088,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-30",
      "transaction_shares": "646",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5081"
    },
    {
      "id": 168438,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-08-30",
      "transaction_shares": "3784",
      "transaction_price": "499",
      "transaction_type": "S",
      "shares_after_transaction": "9994"
    },
    {
      "id": 168482,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-30",
      "transaction_shares": "646",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5081"
    },
    {
      "id": 199361,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-08-30",
      "transaction_shares": "3784",
      "transaction_price": "499",
      "transaction_type": "S",
      "shares_after_transaction": "9994"
    },
    {
      "id": 199405,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-30",
      "transaction_shares": "646",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5081"
    },
    {
      "id": 89165,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-08",
      "transaction_shares": "1292",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5727"
    },
    {
      "id": 113682,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-08",
      "transaction_shares": "1292",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5727"
    },
    {
      "id": 140063,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-08",
      "transaction_shares": "1292",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5727"
    },
    {
      "id": 168457,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-08",
      "transaction_shares": "1292",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5727"
    },
    {
      "id": 199380,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-08",
      "transaction_shares": "1292",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5727"
    },
    {
      "id": 89178,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-08-07",
      "transaction_shares": "2280",
      "transaction_price": "476.75",
      "transaction_type": "S",
      "shares_after_transaction": "23259"
    },
    {
      "id": 113695,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-08-07",
      "transaction_shares": "2280",
      "transaction_price": "476.75",
      "transaction_type": "S",
      "shares_after_transaction": "23259"
    },
    {
      "id": 140076,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-08-07",
      "transaction_shares": "2280",
      "transaction_price": "476.75",
      "transaction_type": "S",
      "shares_after_transaction": "23259"
    },
    {
      "id": 168470,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-08-07",
      "transaction_shares": "2280",
      "transaction_price": "476.75",
      "transaction_type": "S",
      "shares_after_transaction": "23259"
    },
    {
      "id": 199393,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-08-07",
      "transaction_shares": "2280",
      "transaction_price": "476.75",
      "transaction_type": "S",
      "shares_after_transaction": "23259"
    },
    {
      "id": 89222,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "5295",
      "transaction_price": "125.71",
      "transaction_type": "M",
      "shares_after_transaction": "45295"
    },
    {
      "id": 113740,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "5295",
      "transaction_price": "125.71",
      "transaction_type": "M",
      "shares_after_transaction": "45295"
    },
    {
      "id": 140121,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "5295",
      "transaction_price": "125.71",
      "transaction_type": "M",
      "shares_after_transaction": "45295"
    },
    {
      "id": 168516,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "5295",
      "transaction_price": "125.71",
      "transaction_type": "M",
      "shares_after_transaction": "45295"
    },
    {
      "id": 199439,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "5295",
      "transaction_price": "125.71",
      "transaction_type": "M",
      "shares_after_transaction": "45295"
    },
    {
      "id": 89160,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-30",
      "transaction_shares": "15202",
      "transaction_price": "505",
      "transaction_type": "S",
      "shares_after_transaction": "90970"
    },
    {
      "id": 113677,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-30",
      "transaction_shares": "15202",
      "transaction_price": "505",
      "transaction_type": "S",
      "shares_after_transaction": "90970"
    },
    {
      "id": 140057,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-30",
      "transaction_shares": "15202",
      "transaction_price": "505",
      "transaction_type": "S",
      "shares_after_transaction": "90970"
    },
    {
      "id": 168451,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-30",
      "transaction_shares": "15202",
      "transaction_price": "505",
      "transaction_type": "S",
      "shares_after_transaction": "90970"
    },
    {
      "id": 199374,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-30",
      "transaction_shares": "15202",
      "transaction_price": "505",
      "transaction_type": "S",
      "shares_after_transaction": "90970"
    },
    {
      "id": 66992,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-24",
      "transaction_shares": "2280",
      "transaction_price": "488.46",
      "transaction_type": "S",
      "shares_after_transaction": "25539"
    },
    {
      "id": 89171,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-24",
      "transaction_shares": "2280",
      "transaction_price": "488.46",
      "transaction_type": "S",
      "shares_after_transaction": "25539"
    },
    {
      "id": 113688,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-24",
      "transaction_shares": "2280",
      "transaction_price": "488.46",
      "transaction_type": "S",
      "shares_after_transaction": "25539"
    },
    {
      "id": 140069,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-24",
      "transaction_shares": "2280",
      "transaction_price": "488.46",
      "transaction_type": "S",
      "shares_after_transaction": "25539"
    },
    {
      "id": 168463,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-24",
      "transaction_shares": "2280",
      "transaction_price": "488.46",
      "transaction_type": "S",
      "shares_after_transaction": "25539"
    },
    {
      "id": 199386,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-24",
      "transaction_shares": "2280",
      "transaction_price": "488.46",
      "transaction_type": "S",
      "shares_after_transaction": "25539"
    },
    {
      "id": 67035,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-22",
      "transaction_shares": "15202",
      "transaction_price": "497",
      "transaction_type": "S",
      "shares_after_transaction": "106172"
    },
    {
      "id": 89215,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-22",
      "transaction_shares": "15202",
      "transaction_price": "497",
      "transaction_type": "S",
      "shares_after_transaction": "106172"
    },
    {
      "id": 113733,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-22",
      "transaction_shares": "15202",
      "transaction_price": "497",
      "transaction_type": "S",
      "shares_after_transaction": "106172"
    },
    {
      "id": 140114,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-22",
      "transaction_shares": "15202",
      "transaction_price": "497",
      "transaction_type": "S",
      "shares_after_transaction": "106172"
    },
    {
      "id": 168509,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-22",
      "transaction_shares": "15202",
      "transaction_price": "497",
      "transaction_type": "S",
      "shares_after_transaction": "106172"
    },
    {
      "id": 199432,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-22",
      "transaction_shares": "15202",
      "transaction_price": "497",
      "transaction_type": "S",
      "shares_after_transaction": "106172"
    },
    {
      "id": 67029,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-10",
      "transaction_shares": "2280",
      "transaction_price": "487.34",
      "transaction_type": "S",
      "shares_after_transaction": "27819"
    },
    {
      "id": 89209,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-10",
      "transaction_shares": "2280",
      "transaction_price": "487.34",
      "transaction_type": "S",
      "shares_after_transaction": "27819"
    },
    {
      "id": 113727,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-10",
      "transaction_shares": "2280",
      "transaction_price": "487.34",
      "transaction_type": "S",
      "shares_after_transaction": "27819"
    },
    {
      "id": 140108,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-10",
      "transaction_shares": "2280",
      "transaction_price": "487.34",
      "transaction_type": "S",
      "shares_after_transaction": "27819"
    },
    {
      "id": 168503,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-10",
      "transaction_shares": "2280",
      "transaction_price": "487.34",
      "transaction_type": "S",
      "shares_after_transaction": "27819"
    },
    {
      "id": 199426,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-10",
      "transaction_shares": "2280",
      "transaction_price": "487.34",
      "transaction_type": "S",
      "shares_after_transaction": "27819"
    }
  ]
}